ILUVATAR COREX (09903) proposes to implement full circulation of H shares.
ILUVATAR COREX (09903) announces that on October 16, 2026, the Company submitted a filing application to the CSRC in relation to the conversion of 27.647 million unlisted shares of the Company with a par value of RMB1.0 each held by certain domestic shareholders of the Company into H shares of the Company with a par value of RMB1.0 each, representing approximately 3.42% of the total issued share capital of the Company as at the date of this announcement.
ILUVATAR COREX (09903) announces that on October 16, 2026, the Company submitted a filing application to the China Securities Regulatory Commission in relation to the conversion of 27.647 million unlisted shares of the Company with a par value of RMB1.0 per share held by certain domestic shareholders of the Company into H shares of the Company with a par value of RMB1.0 per share, representing approximately 3.42% of the total issued share capital of the Company as at the date of this announcement.
Related Articles
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.
US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall
AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.
US Stock Market Move | Biotech company City Therapeutics (CTY.US) debuts on the U.S. stock market, rising nearly 24% after the open.
US Stock Market Move | Selloff Continues as Nasdaq 100 Plunges 1.3%, Most Star Tech Stocks Fall
AI data center construction demand remains strong; Morgan Stanley is bullish on the outlook for Ethernet and optical communications, favoring Lumentum (LITE.US) and Coherent (COHR.US) amid the stock pullback.
